10 Essential Tremor Clinical Trials in New Brunswick, NJ (2026)

Q: How do I join a clinical trial in New Brunswick?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you.

Recruiting Essential Tremor Studies in New Brunswick

NCT05581004Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

This is a first-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of enzelkitug when administered as a single agent and in combination with atezolizum...

New Brunswick, NJPHASE1450 participantsGenentech, Inc.

View Study Details

NCT06033599Recruiting

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake...

New Brunswick, NJPHASE3420 participantsRutgers, The State University of New Jersey

View Study Details

NCT07348679Recruiting

Cigarette Filter Study

The overall purpose of this study is to determine the effects of using charcoal-filtered cigarettes on product perceptions, smoking behaviors, and biomarkers of exposure to tobacco-related toxicants. ...

New Brunswick, NJNA252 participantsRutgers, The State University of New Jersey

View Study Details

NCT07171684Recruiting

Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)

The goal of this clinical trial is to see if diabetes in pregnancy can be treated with once daily dosing of insulin instead of once daily dosing plus insulin with meals. The main question this study a...

New Brunswick, NJNA176 participantsRutgers, The State University of New Jersey

View Study Details

NCT05398276Recruiting

Behavioral Exposure for Introceptive Tolerance RCT

Behavioral Exposure for Interoceptive Tolerance (BE-FIT) is a mechanism-informed behavioral intervention to target exercise anxiety. The three primary components of BE-FIT include: (1) exposure to fea...

New Brunswick, NJNA146 participantsRutgers, The State University of New Jersey

View Study Details

NCT05419518Recruiting

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

The investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Add...

New Brunswick, NJPHASE2124 participantsRutgers, The State University of New Jersey

View Study Details

NCT07080242Recruiting

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroen...

New Brunswick, NJPHASE1120 participantsSystImmune Inc.

View Study Details

NCT06546085Recruiting

Extracellular Vesicles, Insulin Action, and Exercise

Extracellular vesicles (EVs) play a role in obesity-induced insulin resistance and likely impact the development of cardiovascular disease. However, little is known on how EVs affect vascular insulin ...

New Brunswick, NJNA60 participantsRutgers, The State University of New Jersey

View Study Details

NCT05561907Recruiting

Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical Gastrojejunostomy

Gastric outlet obstruction (GOO) occurs commonly in malignancies involving the periampullary region (cancers originating in the head of the pancreas, duodenum, bile duct, or ampulla) or the distal sto...

New Brunswick, NJNA32 participantsNorthwell Health

View Study Details

NCT07643012Recruiting

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

To evaluate the safety, tolerability, and preliminary efficacy of moderately hypofractionated (15-fraction) MR-guided adaptive pelvic IMRT in patients with endometrial cancer....

New Brunswick, NJNA30 participantsRutgers, The State University of New Jersey

View Study Details

About Essential Tremor Clinical Trials in New Brunswick

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 10 essential tremor clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 1,810 participants. Research is being sponsored by Genentech, Inc., Rutgers, The State University of New Jersey, SystImmune Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in New Brunswick — FAQ

Are there essential tremor clinical trials in New Brunswick?

Yes, there are 10 essential tremor clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Brunswick?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.

Are clinical trials in New Brunswick free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 10 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated July 18, 2026 from ClinicalTrials.gov